Abstract
End-stage renal disease is closely associated with changes in bone and mineral metabolism. In recent times, osteoporosis has become important among hemodialysis (HD) patients. In this study, the investigators sought to evaluate the relationship between bone mineral density (BMD) and biochemical markers of bone turnover among HD patients. A total of 70 uremic patients on a maintenance HD program for at least 1 y were enrolled in the study. All patients were treated with conventional bicarbonated HD for 5 h through the use of low-flux hollow-fiber dialyzers. Bone densitometry was measured by dual energy x-ray absorptiometry in the lumbar spine (LS) and the femoral neck (FN). BMD was classified according to World Health Organization criteria on the basis of BMD T scores. Biochemical bone turnover markers such as calcium, phosphorus, ionized calcium, intact parathyroid hormone, alkaline phosphatase, plasma bicarbonate, blood pH, serum albumin, and hematocrit levels were measured before the HD session in the morning. Male patients (n=37; 52.9%; mean age, 46.2±17.0 y) were assigned to a single study group, and female patients (n=33; 47.1 %; mean age, 44.0±13.1 y) to another. Mean duration of HD treatment was 33.7±28.5 mo in females and 33.0±26.0 mo in males. Among all patients, BMD T scores in the osteopenia/osteoporosis range were observed at the LS in 58 patients (82.8%) and at the FN in 45 patients (64.3%). According to BMD measurements in FN T score, 10% of patients (n=7) were osteoporotic, 54.3% (n=38), osteopenic, and 35.7% (n=25), normal. On the other hand, in LS T score, the results were 47.1% (n=33) osteoporotic, 35.7% (n=25), osteopenic, and 17.1% (n=12), normal. No statistically significant association was found in osteopenia/osteoporosis between sexes according to FN and LS T score (P=.542, P=.267, respectively). No significant relationship was noted between BMD and biochemical markers of bone turnover. A positive correlation was found between FN T scores of BMD and age (r=.413, P=.000). BMD T scores within the range of scores for osteopenia/osteoporosis were observed in 78.5% of patients at the LS and in 58.5% of patients at the FN. The investigators concluded that no correlation could be found between markers of bone turnover and bone mass measurements in both skeletal regions. LS T score results were worse than FN T score results. Elevated alkaline phosphastase levels combined with high intact parathyroid hormone levels are predictive of renal osteodystrophy but not of adynamic bone disease/osteoporosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hruska KA, Teitelbaum SL. Mechanisms of disease—renal osteodystrophy.N Engl J Med. 1995;333:166–174.
Ersoy FF. Osteoporosis in the elderly with chronic kidney disease.Int Urol Nephrol. 2007;39:321–331.
Lobao R, Carvalho AB, Cuppari L, et al. High prevalence of low bone mineral density in predialysis chronic kidney disease patients: bone histomorphometric analysis.Clin Nephrol. 2004;62:432–439.
Lacativa PG, de Mendonca LM, de Mattos P, et al. Risk factors for decreased total body and regional bone mineral density in hemodialysis patients with severe secondary hyperparathyroidism.J Clin Densitom. 2005;8:352–361.
Malluche HH, Monier-Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy.J Am Soc Nephrol. 1994;4:1631–1642.
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.Am J Kidney Dis. 2003;42:1–201.
Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients.Nephrol Dial Transplant. 1999;14:1922–1928.
Ersoy FF, Passadakis SP, Tarn P, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.J Bone Miner Metab. 2006;24:79–86.
Urena P, Bernard-Poenaru O, Ostertag A, et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.Nephrol Dial Transplant. 2003;18:2325–2331.
Kullenberg R, Falch JA. Prevalence of osteoporosis using bone mineral measurements at the calcaneus by dual X-ray and laser (DXL).Osteoporos Int. 2003;14:823–827.
Hampson G, Vaja S, Evans C, et al. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.Nephron. 2002;91:94–102.
Zayour D, Daouk M, Medawar W, Salamoun M, El-Hajj Fuleihan G. Predictors of bone mineral density in patients on hemodialysis.Transplant Proc. 2004;36:1297–1301.
Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W, Sowinski J. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis.Ado Perit Dial. 2001;17:109–113.
Malyszko J, Brzosko S, Wolczynski S, Malyszko JS, Mysliwiec M. Bone metabolism in dialysis patients assessed by biochemical markers and densitometry.Pol Arch Med Wewn. 2003;110:967–972.
Yucel AE, Kart-Koseoglu H, Isiklar I, et al. Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection.Ren Fail. 2004;26:159–164.
Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.Am J Kidney Dis. 2000;36:1115-U21.
Jadoul M, Albert JM, Akiba T, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.Kidney Int. 2006;70:1358–1366.
Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca × PO(4) product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.J Am Soc Nephrol. 2001;12:2131–2138.
Lemann J Jr, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans.Am J Physiol Renal Physiol. 2003;285:F811-F832.
Movilli E, Zani R, Carli O, et al. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.Nephron. 2001;87:257–262.
Mathur RP, Dash SC, Gupta N, et al. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial.Ren Fail. 2006;28:1–5.
Negri AL, Barone R, Quiroga MA, et al. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.Perit Dial Int. 2004;24:163–168.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sit, D., Kadiroglu, A.K., Kayabasi, H. et al. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients. Adv Therapy 24, 987–995 (2007). https://doi.org/10.1007/BF02877703
Issue Date:
DOI: https://doi.org/10.1007/BF02877703